agilon health, inc. (NYSE:AGL) Given Average Rating of “Hold” by Brokerages

Shares of agilon health, inc. (NYSE:AGL) have been assigned an average rating of “Hold” from the eighteen research firms that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, fourteen have issued a hold recommendation and two have given a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $4.03.

Several research firms have issued reports on AGL. Needham & Company LLC started coverage on agilon health in a research note on Friday, January 10th. They set a “hold” rating for the company. Evercore ISI cut their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. TD Cowen reduced their price objective on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $3.00 target price on shares of agilon health in a research note on Tuesday, November 19th. Finally, Macquarie assumed coverage on shares of agilon health in a research note on Monday, December 16th. They issued a “neutral” rating and a $3.00 price target on the stock.

Insider Activity

In other news, Director John William Wulf acquired 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Diana Mckenzie bought 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were purchased at an average price of $2.28 per share, with a total value of $28,500.00. Following the purchase, the director now owns 51,319 shares of the company’s stock, valued at approximately $117,007.32. This represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 90,000 shares of company stock worth $198,100. Corporate insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Hedge funds and other institutional investors have recently bought and sold shares of the business. Inspire Investing LLC increased its holdings in shares of agilon health by 106.6% in the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock valued at $413,000 after acquiring an additional 112,241 shares during the last quarter. Oak Thistle LLC purchased a new position in agilon health in the fourth quarter valued at approximately $25,000. Pines Wealth Management LLC acquired a new stake in agilon health during the fourth quarter worth approximately $51,000. JPMorgan Chase & Co. lifted its position in shares of agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after buying an additional 1,083,492 shares during the last quarter. Finally, Virtu Financial LLC acquired a new position in shares of agilon health in the 3rd quarter valued at $120,000.

agilon health Trading Up 5.2 %

Shares of AGL stock opened at $3.12 on Friday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a twelve month low of $1.50 and a twelve month high of $7.73. The company’s 50-day moving average price is $2.10 and its 200-day moving average price is $3.63. The stock has a market cap of $1.28 billion, a price-to-earnings ratio of -3.31 and a beta of 0.53.

agilon health (NYSE:AGL) last posted its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the previous year, the firm earned ($0.06) earnings per share. As a group, equities analysts predict that agilon health will post -0.59 earnings per share for the current year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.